Dr. Vishal Gupta, MD

Dr. Gupta practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Dr. Gupta's NPI, 1275516338, was assigned on November 22, 2005. Dr. Gupta graduated from Rush Medical College in 2003. Dr. Gupta holds New York license 252361.

Dr. Gupta's primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Dr. Gupta's primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Dr. Gupta is also affiliated with Mount Sinai Beth Israel. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Gupta to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gupta is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Gupta's licenses on file in 2 states: New York and California.

Dmand AI lists anal cancer radiation, bone cancer radiation, breast cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Gupta treats.

CMS data shows 202 Medicare services from Dr. Gupta across 7 procedure codes in 2024, for 65 Medicare patients. Medicare paid $20,319 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Dr. Gupta in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 66, with 78% women.

In 2024, Dr. Gupta wrote 28 Medicare Part D claims for 11 patients. 93% of them were for generic drugs. They cover 2 drugs, with $370 in total drug cost. In 2018, CMS named 16 claims across 1 drug.

Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth.

Dmand AI links 451 papers to Dr. Gupta, published from 2005 to 2025. 2017 was the busiest year, with 38. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Diagnosis, Differential. Dr. Gupta has published most often in Indian J Dermatol Venereol Leprol. Dr. Gupta's most frequent co-authors are Richard L. Bakst, MD, Eric M. Genden, MD and Marshall R. Posner, MD.

Dmand AI links Dr. Gupta to 1 clinical trial. Conditions studied include Heart Failure and Diabetes Mellitus, Type 2. Open Payments lists research payments to Dr. Gupta that name 1 trial.

CMS Open Payments shows 17 general payments to Dr. Gupta from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $496. It also lists 12 research payments totaling $1,243 in 2018, naming 1 clinical trial.

Dr. Gupta graduated from Rush Medical College in 2003.

Dr. Gupta is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.